Brookmont Capital Management Abbott Laboratories Transaction History

Brookmont Capital Management

$194 Million
Q3 2024

A detailed history of Brookmont Capital Management transactions in Abbott Laboratories stock. As of the latest transaction made, Brookmont Capital Management holds 42,629 shares of ABT stock, worth $4.83 Million. This represents 2.5% of its overall portfolio holdings.

Number of Shares

42,629

Previous 44,137 3.42%

Holding current value

$4.83 Million

Previous $4.59 Million 5.97%

% of portfolio

2.5%

Previous 2.51%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 16, 2024	SELL	$100.07 - $118.13 $150,905 - $178,140	-1,508 Reduced 3.42%	42,629 $4.86 Million
Q2 2024 Jul 17, 2024	SELL	$100.73 - $112.44 $12,188 - $13,605	-121 Reduced 0.27%	44,137 $4.59 Million
Q1 2024 Apr 16, 2024	BUY	$109.52 - $120.96 $11,937 - $13,184	109 Added 0.25%	44,258 $5.03 Million
Q4 2023 Jan 18, 2024	BUY	$90.19 - $110.4 $13,077 - $16,008	145 Added 0.33%	44,149 $4.86 Million
Q3 2023 Oct 12, 2023	BUY	$95.53 - $114.62 $254,396 - $305,233	2,663 Added 6.44%	44,004 $4.26 Million
Q2 2023 Jul 13, 2023	SELL	$100.78 - $112.29 $3,527 - $3,930	-35 Reduced 0.08%	41,341 $4.51 Million
Q1 2023 Apr 11, 2023	BUY	$96.86 - $114.01 $16,078 - $18,925	166 Added 0.4%	41,376 $4.19 Million
Q4 2022 Feb 06, 2023	BUY	$95.06 - $111.52 $313,222 - $367,458	3,295 Added 8.69%	41,210 $4.53 Million
Q3 2022 Oct 12, 2022	BUY	$96.76 - $112.03 $239,384 - $277,162	2,474 Added 6.98%	37,915 $3.67 Million
Q2 2022 Aug 15, 2022	BUY	$102.07 - $123.37 $6,634 - $8,019	65 Added 0.18%	35,441 $3.85 Million
Q1 2022 May 09, 2022	BUY	$114.02 - $139.04 $25,996 - $31,701	228 Added 0.65%	35,376 $4.19 Million
Q4 2021 Jan 27, 2022	SELL	$115.53 - $141.46 $195,245 - $239,067	-1,690 Reduced 4.59%	35,148 $4.95 Million
Q3 2021 Nov 15, 2021	SELL	$116.66 - $129.06 $15,515 - $17,164	-133 Reduced 0.36%	36,838 $4.35 Million
Q2 2021 Jul 19, 2021	BUY	$105.79 - $124.53 $3,914 - $4,607	37 Added 0.1%	36,971 $4.29 Million
Q1 2021 Apr 15, 2021	SELL	$108.84 - $128.23 $55,726 - $65,653	-512 Reduced 1.37%	36,934 $4.43 Million
Q4 2020 Feb 04, 2021	SELL	$105.0 - $114.42 $330,540 - $360,194	-3,148 Reduced 7.75%	37,446 $4.1 Million
Q3 2020 Oct 16, 2020	BUY	$91.64 - $111.29 $48,569 - $58,983	530 Added 1.32%	40,594 $4.42 Million
Q2 2020 Jul 23, 2020	SELL	$76.57 - $98.0 $738,441 - $945,112	-9,644 Reduced 19.4%	40,064 $3.66 Million
Q1 2020 Apr 28, 2020	SELL	$62.82 - $91.86 $61,689 - $90,206	-982 Reduced 1.94%	49,708 $3.92 Million
Q4 2019 Jan 22, 2020	SELL	$78.51 - $87.4 $317,494 - $353,445	-4,044 Reduced 7.39%	50,690 $4.4 Million
Q3 2019 Nov 07, 2019	BUY	$81.84 - $88.74 $622,802 - $675,311	7,610 Added 16.15%	54,734 $4.58 Million
Q2 2019 Jul 18, 2019	BUY	$72.88 - $85.0 $6,704 - $7,820	92 Added 0.2%	47,124 $3.96 Million
Q1 2019 Apr 16, 2019	BUY	$66.22 - $80.06 $2,979 - $3,602	45 Added 0.1%	47,032 $3.76 Million
Q4 2018 Feb 12, 2019	SELL	$65.56 - $74.27 $705,687 - $799,442	-10,764 Reduced 18.64%	46,987 $3.4 Million
Q3 2018 Nov 08, 2018	SELL	$60.81 - $73.36 $9,121 - $11,004	-150 Reduced 0.26%	57,751 $4.24 Million
Q2 2018 Jul 19, 2018	BUY	$57.57 - $63.54 $6,217 - $6,862	108 Added 0.19%	57,901 $3.53 Million
Q1 2018 May 14, 2018	SELL	$56.27 - $63.62 $2.99 Million - $3.38 Million	-53,202 Reduced 47.93%	57,793 $3.46 Million
Q4 2017 Feb 12, 2018	BUY	$53.68 - $57.47 $1.68 Million - $1.8 Million	31,267 Added 39.22%	110,995 $6.34 Million
Q3 2017 Nov 13, 2017	BUY	$48.06 - $53.64 $3.83 Million - $4.28 Million	79,728	79,728 $4.25 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $198B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brookmont Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Brookmont Capital Management with notifications on news.

Account

Brookmont Capital Management Abbott Laboratories Transaction History